CATEGORIES

Healthcare

LATEST

TRENDING

EDITORS CHOICE

TaiGen files US IND for its influenza antiviral TG-1000

TaiGen Biotechnology Company, announced today that it has filed an IND application with the US FDA for its influenza antiviral TG-1000.

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

ZEPOSIA, a treatment for multiple sclerosis is the first and only approved sphingosine-1-phosphate (S1P) receptor modulator with no genetic test or first dose observation at initiation

Sorry Night Owl, Early Bird are Healthier

Are you the type of person who is more active at night, stays up more often, and sleeps during the day? Here are seven steps you can do if you’re a night owl.

Were the Billions Invested in Alzheimer’s Research Worthwhile?

It may seem that the COVID-19 vaccines appeared almost suddenly, like rabbits pulled from a magician’s hat, but the invention of mRNA-based vaccines that...